Key result
Observational studies suggest that statin use is associated with reduced hospital mortality in acutely ill patients, indicating that large randomized controlled trials are long overdue to confirm these benefits.
Why the study?
Do statins reduce hospital mortality and improve survival in acutely hospitalized patients?
Do statins reduce hospital mortality and improve survival in acutely hospitalized patients?
Answers are grounded in this paper and cite their sources.
This commentary emphasizes the growing observational evidence that statins reduce mortality in acutely hospitalized patients via pleiotropic immune-modulating effects, calling for definitive randomized controlled trials.
From the earliest studies of statins for control of plasma cholesterol, observations have been made that the reductions in mortality observed occurred in a manner seemingly independent from what could be anticipated from cholesterol lowering alone. Over the last decade, the pleiotropic effects of statins have been increasingly elucidated. Perhaps most intriguing are the effects statins appear to have on the immune system, especially the modulation of diffuse or systemic inflammation. There is a growing body of observational literature suggesting that statins can actually reduce hospital mortality through mechanisms far beyond those that can be explained by reductions in cardiovascular events.
No takes yet. Share an insight, caveat, or question.
Gordon R. Bernard (2010) conducted an editorial in Acute hospitalization and critical illness. Statins was evaluated. Observational studies suggest that statin use is associated with reduced hospital mortality in acutely ill patients, indicating that large randomized controlled trials are long overdue to confirm these benefits.
Synapse has enriched 10 related papers. Consider them for comparative context: